C. H. D. Kaa

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Christina A Hulsbergen-van De Kaa, C. A. Hulsbergen Van De Kaa, C. A. Hulsbergen-van De Kaa, C. A. De Hulsbergen-van Kaa, Christina A. Hulsbergen-van De Kaa, Christine Van De Kaa, Christina Hulsbergen-van De Kaa, C. H. Van De Kaa
Publication record
32 papers · 998 citations · H-index 8

PAPERS

The SelectMDx urinary-biomarker test: Role in the detection of high-grade prostate cancer and in combination with multi-parametric magnetic resonance imaging in a contemporary prospective cohort of biopsy-naïve men
20200 citationsauthor #7
PD53-04 THE SELECTMDX URINARY-BIOMARKER TEST
20200 citationsauthor #7
Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study.
202034 citationsauthor #15
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, non-invasive bladder tumors in 2019?
20191 citationsauthor #50
Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study.
20199 citationsauthor #11
Combining multi-parametric M.R.I and an epigenetic biomarker assay improves patient prostate cancer risk profile
20180 citationsauthor #5
MP46-11 EVALUATION OF TWO URINARY RNA BIOMARKER TESTS WITH AN EPIGENETIC DNA ASSAY FOR THE IDENTIFICATION OF MEN WITH HIGH-GRADE PROSTATE CANCER
20180 citationsauthor #6
Variation in pelvic lymph node dissection among prostate cancer patients in the Netherlands: Are we using a double standard for radical prostatectomy and radiotherapy patients?
20180 citationsauthor #8
Curcumin as Treatment for Bladder Cancer: A Preclinical Study of Cyclodextrin-Curcumin Complex and BCG as Intravesical Treatment in an Orthotopic Bladder Cancer Rat Model
201830 citationsauthor #4
Myeloid and plasmacytoid dendritic cell vaccinations for castration-resistant prostate cancer patients.
20182 citationsauthor #7
MP02-02 MULTICENTER VALIDATION STUDY OF A MOLECULAR URINE TEST TO PREDICT HIGH-GRADE PROSTATE CANCER.
20160 citationsauthor #14
383 Multicenter validation study of a urine-based molecular biomarker algorithm to predict high-grade prostate cancer
20160 citationsauthor #16
Elevated HOXC6/DLX1 mRNA biomarker levels in urine to help select patients at increased risk for high-grade prostate cancer detection upon prostate biopsy.
20163 citationsauthor #14
University of Birmingham Bilateral testicular tumors resulting in recurrent Cushing's syndrome after bilateral adrenalectomy
20161 citationsauthor #5
Identi fi cation of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer
20152 citationsauthor #12
957 Role of repeat 3T multiparametric MR imaging and MR-guided biopsy versus repeat TRUS-guided biopsies after 1 year follow-up in low-risk prostate cancer patients in an active surveillance protocol
20140 citationsauthor #5
996 Staging of bladder cancer (pta vs pt1) among 238 European pathologists
20140 citationsauthor #9
351 QUATTRO, a four gene prognostic biomarker panel for prostate cancer
20141 citationsauthor #12
287 A consensus study on invasiveness of bladder cancer using virtual microscopy and heatmaps (pT1 ENUP (European Network of UroPathology) study
20130 citationsauthor #9
The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
2013198 citationsauthor #5
Selenium induces an anti-inflammatory gene expression profile in prostate tissue
20110 citationsauthor #6
Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers
2010195 citationsauthor #5
628 THE LENGTH OF POSITIVE SURGICAL MARGINS CORRELATES WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
20090 citationsauthor #4
298 VALUE OF 3 TESLA MULTIMO DALITY MR GUIDED BIOPSY (MRGB) TO DETECT PROSTATE CANCER IN PATIENTS AFTER AT LEAST TWO PREVIOUS NEGATIVE BIOPSIES AND AN ELEVATED PSA
20093 citationsauthor #5
THE CORRELATION BETWEEN THE LENGTH OF POSITIVE SURGICAL MARGINS AND BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER
20081 citationsauthor #4
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
2008419 citationsauthor #14
103 ARE SMALL-VOLUME PROSTATE CANCERS INSIGNIFICANT?
20071 citationsauthor #5
122 BIOCHEMICAL OUTCOME OF PT3 PROSTATE CANCER AFTER RADICAL PROSTATECTOMY
20070 citationsauthor #6
Polymorphisms in genes related to activation or detoxification of carcinogens might increase renal cancer risk: results from the Netherlands Cohort Study Maastricht
20070 citationsauthor #5
Cigarette smoking, von Hippel–Lindau gene mutations and sporadic renal cell carcinoma
200622 citationsauthor #5
Identification of novel familial cases of renal cell cancer and ascertainment of a newly isolated predisposing gene
20010 citationsauthor #2
Amplification of chromosome subregion 12p11.2-p12.1 in a metastasis of an i(12p)-negative seminoma: relationship to tumor progression?
199477 citationsauthor #8

TIMELINE

1994 77 citations

2001 0 citations

2006 22 citations

2007 1 citations

2008 420 citations

2009 3 citations

2010 195 citations

2011 0 citations

2013 198 citations

2014 1 citations

2015 2 citations

2016 4 citations

2018 32 citations

2019 10 citations

2020 34 citations

C. H. D. Kaa

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT